{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:45:00Z","timestamp":1789429500485,"version":"build-2803163510"},"reference-count":147,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL155301"],"award-info":[{"award-number":["R01HL155301"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R61HL158529"],"award-info":[{"award-number":["R61HL158529"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Intensive Care Med"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients experiencing significant agitation or perceptual disturbances related to delirium in an intensive care setting may benefit from short-term treatment with an antipsychotic medication. Some antipsychotic medications may prolong the QTc interval, which increases the risk of potentially fatal ventricular arrhythmias. In this targeted review, we describe the evidence regarding the relationships between antipsychotic medications and QTc prolongation and practical methods for monitoring the QTc interval and mitigating arrhythmia risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Searches of PubMed and Cochrane Library were performed to identify studies, published before February 2023, investigating the relationships between antipsychotic medications and QTc prolongation or arrhythmias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Most antipsychotic medications commonly used for the management of delirium symptoms (eg, intravenous haloperidol, olanzapine, quetiapine) cause a moderate degree of QTc prolongation. Among other antipsychotics, those most likely to cause QTc prolongation are iloperidone and ziprasidone, while aripiprazole and lurasidone appear to have minimal risk for QTc prolongation. Genetic vulnerabilities, female sex, older age, pre-existing cardiovascular disease, electrolyte abnormalities, and non-psychiatric medications also increase the risk of QTc prolongation. For individuals at risk of QTc prolongation, it is essential to measure the QTc interval accurately and consistently and consider medication adjustments if needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Antipsychotic medications are one of many risk factors for QTc prolongation. When managing agitation related to delirium, it is imperative to assess an individual patient's risk for QTc prolongation and to choose a medication and monitoring strategy commensurate to the risks. In intensive care settings, we recommend regular ECG monitoring, using a linear regression formula to correct for heart rate. If substantial QTc prolongation (eg, QTc\u2009&gt;\u2009500 msec) is present, a change in pharmacologic treatment can be considered, though a particular medication may still be warranted if the risks of discontinuation (eg, extreme agitation, removal of invasive monitoring devices) outweigh the risks of arrhythmias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This review aims to summarize the current literature on relationships between antipsychotic medications and QTc prolongation and to make practical clinical recommendations towards the approach of antipsychotic medication use for the management of delirium-related agitation and perceptual disturbances in intensive care settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/08850666231222470","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T02:34:36Z","timestamp":1703212476000},"page":"355-371","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":14,"title":["Risk Stratification of QTc Prolongation in Critically Ill Patients Receiving Antipsychotics for the Management of Delirium Symptoms"],"prefix":"10.1177","volume":"40","author":[{"given":"Monika","family":"Sadlonova","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA"},{"name":"Department of Psychiatry, Harvard Medical School, Boston, MA, USA"},{"name":"Department of Psychosomatic Medicine and Psychotherapy, University of G\u00f6ttingen Medical Center, G\u00f6ttingen, Germany"},{"name":"Department of Cardiovascular and Thoracic Surgery, University of G\u00f6ttingen Medical Center, G\u00f6ttingen, Germany"},{"name":"DZHK (German Center for Cardiovascular Research), Partner Site G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott R.","family":"Beach","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA"},{"name":"Department of Psychiatry, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margo C.","family":"Funk","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Harvard Medical School, Boston, MA, USA"},{"name":"Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan H.","family":"Rosen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Harvard Medical School, Boston, MA, USA"},{"name":"Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres F.","family":"Ramirez Gamero","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA"},{"name":"Department of Psychiatry, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Karlson","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff C.","family":"Huffman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA"},{"name":"Department of Psychiatry, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0547-2851","authenticated-orcid":false,"given":"Christopher M.","family":"Celano","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA"},{"name":"Department of Psychiatry, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,12,21]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.08.067"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.resuscitation.2021.02.029"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022147"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199810013391404"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93774-9"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-019-05477-7"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ancard.2010.12.002"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra032426"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaclp.2021.02.003"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2017.10.009"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jelectrocard.2017.12.039"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-017-2381-5"},{"issue":"8","key":"e_1_3_3_14_2","article-title":"Diagnosing Torsades De Pointes based on correlation to QT interval: a systematic review","volume":"14","author":"Kahlon SS","year":"2022","unstructured":"Kahlon SS, Sikandar R, Tejovath S, et al. Diagnosing Torsades De Pointes based on correlation to QT interval: a systematic review. Cureus. 2022;14(8):e27833. https:\/\/doi.org\/10.7759\/cureus.27833","journal-title":"Cureus"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2022-0027"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2012.11.001"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.1760501"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-016-0414-2"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200124050-00001"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.2174\/157488610789869265"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000014448.19052.4C"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2022.114891"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2021.05.040"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.03.024"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238867"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2023.100618"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05850809"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/aas.13661"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2211868"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1808217"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2214417"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.06.002"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2022.10.010"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2019.05.003"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31135-3"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2018.1516106"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2022.02.017"},{"issue":"4","key":"e_1_3_3_38_2","first-page":"739","article-title":"Congenital long QT syndrome: a systematic review","volume":"60","author":"Gali\u0107 E","year":"2021","unstructured":"Gali\u0107 E, Be\u0161li\u0107 P, Kili\u0107 P, et al. Congenital long QT syndrome: a systematic review. Acta Clin Croat. 2021;60(4):739-748. https:\/\/doi.org\/10.20471\/acc.2021.60.04.22","journal-title":"Acta Clin Croat"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001501"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1177\/2045125319891386"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/pace.12864"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2022.08.010"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001568"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2018.03.17"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2540"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.11.1774"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2020.08.008"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199104000-00021"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(95)71710-8"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000104913.75206.62"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60733-3"},{"key":"e_1_3_3_52_2","volume-title":"Briefing Document for Zeldox Capsules (Ziprasidone)","author":"FDA","year":"2000","unstructured":"FDA. Briefing Document for Zeldox Capsules (Ziprasidone). Pfizer Inc; 2000."},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.5.441"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.7.1149"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270004267807"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1781(03)00107-0"},{"issue":"6","key":"e_1_3_3_57_2","first-page":"1","article-title":"Antipsychotics and the risks of sudden cardiac death and all-cause death: cohort studies in medicaid and dually-eligible medicaid-medicare beneficiaries of five states","volume":"10","author":"Leonard CE","year":"2013","unstructured":"Leonard CE, Freeman CP, Newcomb CW, et al. Antipsychotics and the risks of sudden cardiac death and all-cause death: cohort studies in medicaid and dually-eligible medicaid-medicare beneficiaries of five states. J Clin Exp Cardiolog. 2013;Suppl 10(6):1-9. https:\/\/doi.org\/10.4172\/2155-9880.S10-006","journal-title":"J Clin Exp Cardiolog"},{"key":"e_1_3_3_58_2","unstructured":"Sos J Cassem NH. The intravenous use of haloperidol for acute delirium in intensive care settings: Psychic and neurological dysfunctions after open heart surgery. 196th ed; 1980."},{"issue":"5","key":"e_1_3_3_59_2","first-page":"1","article-title":"Practice guideline for the treatment of patients with delirium. American Psychiatric Association","volume":"156","year":"1999","unstructured":"Practice guideline for the treatment of patients with delirium. American Psychiatric Association. Am J Psychiatry. 1999;156(5 Suppl):1-20.","journal-title":"Am J Psychiatry"},{"key":"e_1_3_3_60_2","unstructured":"United States Food and Drug Administration. Information for healthcare professionals: Haloperidol: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/015923s082 018701s057lbl.pdf; 2007; 2007."},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1002\/jhm.691"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc11933"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2010.01.008"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00888-6"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1177\/00912700122012896"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2014.09.048"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1991.tb01421.x"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1002\/hup.540"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705283"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.71.2.210"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02035-3"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199411000-00028"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2003.05.006"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12527"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2015.03.016"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12272"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e31827dde8d"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2014.12.024"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-020-03049-x"},{"key":"e_1_3_3_80_2","unstructured":"Eli Lilly and Company. Package insert. Zyprexa (Olanzapine) 2009."},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-6723.2009.01190.x"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2012.07.118"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1111\/acem.12842"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2016.07.033"},{"key":"e_1_3_3_85_2","article-title":"Intravenous olanzapine for acute agitation in the intensive care unit","volume":"195","author":"Prekker ME","year":"2017","unstructured":"Prekker ME, Klein LR, Vipond JA, et al. Intravenous olanzapine for acute agitation in the intensive care unit. Am J Respir Crit Care Med. 2017;195:A5824.","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2016.08.008"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1177\/1060028019831634"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.1177\/0018578718823484"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1177\/0018578718823484"},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199937030-00001"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000109453.57709.E2"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2021.09.052"},{"key":"e_1_3_3_93_2","unstructured":"AstraZeneca. Seroquel\u00ae (quetiapine fumarate) package insert 2013."},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181b9e302"},{"key":"e_1_3_3_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2010.05.006"},{"issue":"10","key":"e_1_3_3_96_2","first-page":"2158","article-title":"An open-label study of quetiapine for delirium","volume":"90","author":"Maneeton B","year":"2007","unstructured":"Maneeton B, Maneeton N, Srisurapanont M. An open-label study of quetiapine for delirium. J Med Assoc Thai. 2007;90(10):2158-2163.","journal-title":"J Med Assoc Thai"},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n1106"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2018.07.005"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31827c0314"},{"key":"e_1_3_3_100_2","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000124"},{"key":"e_1_3_3_101_2","doi-asserted-by":"publisher","DOI":"10.1177\/1060028020944409"},{"key":"e_1_3_3_102_2","doi-asserted-by":"publisher","DOI":"10.1177\/1060028019829494"},{"key":"e_1_3_3_103_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.609678"},{"key":"e_1_3_3_104_2","doi-asserted-by":"publisher","DOI":"10.1177\/08971900211025148"},{"key":"e_1_3_3_105_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-013-3192-8"},{"key":"e_1_3_3_106_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318283983f"},{"key":"e_1_3_3_107_2","doi-asserted-by":"publisher","DOI":"10.1111\/acem.14124"},{"key":"e_1_3_3_108_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.43.1.61"},{"key":"e_1_3_3_109_2","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2021.01.006"},{"key":"e_1_3_3_110_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200409000-00031"},{"key":"e_1_3_3_111_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270005276485"},{"key":"e_1_3_3_112_2","unstructured":"Pfizer Inc. Package insert. Geodon\u00ae Capsules (ziprasidone HCl) and Geodon\u00ae for Injection (ziprasidone mesylate). 2008."},{"key":"e_1_3_3_113_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.47.3.264"},{"key":"e_1_3_3_114_2","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyz046"},{"key":"e_1_3_3_115_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06293-4"},{"key":"e_1_3_3_116_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)01188-8"},{"key":"e_1_3_3_117_2","doi-asserted-by":"publisher","DOI":"10.1155\/2007\/529076"},{"key":"e_1_3_3_118_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2018.5738"},{"key":"e_1_3_3_119_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.7.681"},{"key":"e_1_3_3_120_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0903"},{"key":"e_1_3_3_121_2","doi-asserted-by":"publisher","DOI":"10.1111\/psyg.12088"},{"key":"e_1_3_3_122_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-011-0678-1"},{"key":"e_1_3_3_123_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(03)00050-1"},{"key":"e_1_3_3_124_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0910"},{"key":"e_1_3_3_125_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-015-4024-9"},{"key":"e_1_3_3_126_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-014-0196-9"},{"key":"e_1_3_3_127_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13128"},{"key":"e_1_3_3_128_2","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2338"},{"key":"e_1_3_3_129_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2019.06.008"},{"key":"e_1_3_3_130_2","doi-asserted-by":"publisher","DOI":"10.5498\/wjp.v11.i12.1228"},{"key":"e_1_3_3_131_2","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000427"},{"key":"e_1_3_3_132_2","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511919237"},{"key":"e_1_3_3_133_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200418130-00007"},{"key":"e_1_3_3_134_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2007.00008.x"},{"key":"e_1_3_3_135_2","unstructured":"Fanapt (iloperidone) (package insert): Available online at https:\/\/www.fanapt.com\/product\/pi\/pdf\/fanapt.pdf (Accessed on September 11 2015). Vanda Pharmaceutical Inc; 2014."},{"key":"e_1_3_3_136_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-4679(03)00044-1"},{"key":"e_1_3_3_137_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.10075su1.05"},{"key":"e_1_3_3_138_2","article-title":"Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia","volume":"10","author":"Tardy M","year":"2014","unstructured":"Tardy M, Huhn M, Engel RR, Leucht S. Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia. Cochrane Database Syst Rev. 2014;10:CD009369. https:\/\/doi.org\/10.1002\/14651858.CD009369.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_139_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2015.11.008"},{"key":"e_1_3_3_140_2","doi-asserted-by":"publisher","DOI":"10.1177\/20451253221104947"},{"key":"e_1_3_3_141_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.12.014"},{"key":"e_1_3_3_142_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1540-8167.2002.01211.x"},{"key":"e_1_3_3_143_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2020.110138"},{"key":"e_1_3_3_144_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-03364-y"},{"key":"e_1_3_3_145_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-022-01811-5"},{"key":"e_1_3_3_146_2","doi-asserted-by":"publisher","DOI":"10.1111\/pan.12780"},{"key":"e_1_3_3_147_2","doi-asserted-by":"publisher","DOI":"10.1177\/08971900211044687"},{"key":"e_1_3_3_148_2","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13548"}],"container-title":["Journal of Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08850666231222470","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/08850666231222470","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08850666231222470","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:57:54Z","timestamp":1777503474000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/08850666231222470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":147,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1177\/08850666231222470"],"URL":"https:\/\/doi.org\/10.1177\/08850666231222470","relation":{},"ISSN":["0885-0666","1525-1489"],"issn-type":[{"value":"0885-0666","type":"print"},{"value":"1525-1489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,21]]}}}